Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)
Study sponsor: Imunon
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2020-04-27Actual
Enrollment · participants554Actual
Source updated2024-08-20Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.